semaglutide appetite GLP-1 Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response Semaglutide Information – Neuday

The company said earlier this year that five GLP-1 drugs now account for nearly 20% of its pharmacy spend, having spent more than $300 million on them in 2024

Medical weight loss plans with diet These medications are for patients who have struggled with losing weight and have at least 10 pounds to lose

Tirzepatide produced an average weight loss of 20.2% compared to 13.7% with semaglutide over 72 weeks

It has plausible biology and promising preclinical findings, but current human evidence does not show that it causes meaningful fat loss

Carrying excess body weight increases metabolic stress, disrupts sleep quality, and elevates inflammatory markersall contributors to low energy levels